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Abstract: Chitin and chitosan are natural polysaccharide polymers. These polymers have 
been used in several agricultural, food protection and nutraceutical applications. Moreover, 
chitin and chitosan have been also used in biomedical and biotechnological applications as 
drug delivery systems or in pharmaceutical formulations. So far, there are only few studies 
dealing  with  arsenic  (As)  removal  from  groundwater  using  chitin  or  chitosan  and  no 
evidence of the use of these natural polymers for arsenic trioxide (As2O3) delivery in tumor 
therapy. Here we suggest that chitin and/or chitosan might have the right properties to be 
employed  as  efficient  polymers  for  such  applications.  Besides,  nanotechnology  offers 
suitable tools for the fabrication of novel nanostructured materials of natural origin. Since 
different  nanostructured  materials  have  already  been  employed  successfully  in  various 
multidisciplinary  fields,  we  expect  that  the  integration  of  nanotechnology  and  natural 
polymer  chemistry  will  further  lead  to  innovative  applications  for  environment  
and medicine. 
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1. Introduction 
Chitin is an abundant natural polysaccharide produced by arthropods and crustaceans. Chitin is 
found  in  diatoms,  nematodes,  molluscs  and  as  a  structural  polysaccharide  in  basidiomycetes  and 
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filamentous fungal cell walls, constituting almost 16% of the dry weight of the organism [1]. Chitin 
deacetylation leads to the formation of chitosan. The process involves the use of strong alkali solutions 
for the removal of N-acetyl groups both at room or elevated temperatures [2,3]. Chitin and chitosan are 
suitable  functional  materials  due  to  their  excellent  properties  such  as  biocompatibility, 
biodegradability, non-toxicity and adsorption properties, to cite only a few [4]. Chitin and chitosan are 
highly basic polysaccharides with unique properties like the ability to form films [5] to react with 
polyanions  [6,7]  as  well  as  to  chelate  and  remove  metal  ions  [8].  A  wide  variety  of  medical 
applications for chitin and chitosan derivatives have been reported in the last few years [9–11]. 
However,  the  versatitily  of  chitin  and  chitosan  was  emphasized  in  two  recent,  and  somehow 
controversial, applications in the field of arsenic chemistry. In fact, the potential of chitin and chitosan 
can be exploited either for inorganic arsenic removal in groundwater or in the design of novel delivery 
vectors for arsenic trioxide (As2O3) in tumor therapy. While a high dose of inorganic arsenic (iAs) is 
toxic for individuals, As2O3 is used as an antineoplastic agent in most common malignancies. We think 
that  this  interesting  paradoxical  behavior  merits  a  deeper  investigation  in  the  near  future  by 
investigators and clinicians involved in these two different research fields. 
2. Chitin and Chitosan for Arsenic Species Complexation and Removal 
Arsenic  (As)  is  a  metalloid  that  occurs  naturally  in  the  environment  and  is  present  in  soil, 
groundwater and plants [12]. Inorganic arsenic (iAs) is the most toxic form, and has been classified in 
group 1 as carcinogenic to humans by the International Agency for Research on Cancer [13]. In fact, 
arsenic may induce lung, urinary bladder and primary skin cancer.  
In China, India and Bangladesh, As contamination ([As] > 100.000 g/L) of groundwater used for 
drinking is a serious threat for human health [14]. The WHO provisional guideline value for arsenic in 
drinking water has been set to 10 g/L [15]. Moreover, some cereal grains and cereal-based products 
(i.e., rice) can be contaminated by a high amount of arsenic. Besides, the influence of processing and 
cooking of these foods should be taken into account if iAs-contaminated water is used [16,17]. The 
need to regulate As exposure in infants consuming rice-based products has been recently highlighted 
by us since the European Union has not fixed a maximum tolerable limit for these foods so far [18]. 
Therefore, the identification and use of low-cost methods and safe materials to remove As from 
drinking water is highly desirable [19]. Several methods are available for the removal of As and have 
been  reviewed  by  Mohan  et  al.  [20].  Among  them,  we  mention  co-precipitation,  flotation,  ion 
exchange, ultrafiltration, and reverse osmosis. Arsenic adsorption from aqueous solution has received 
more attention due to its higher efficiency. Activated alumina [21], activated carbon [22] and bauxsol 
[23] have been used as efficient adsorbents. Even goethite and hematite [24], iron oxide-coated sand 
[25], ferrihydrite [26], and Fe(III)-loaded resins [27] have been employed because of the selectivity 
and affinity of Fe(III) toward iAs species. Although these resins are efficient and selective in removing 
As, their applicability is limited due to their high cost. For these reasons, adsorption of arsenic using 
natural products has emerged as a viable option [28,29]. Chitin and chitosan have been reported to be 
efficient heavy metal scavengers due to the presence of hydroxyl and amino groups [30]. In a recent 
study by Sun et al. [31] it was observed that sulfur atoms also have a strong affinity for arsenic. 
Therefore, the authors prepared polyaspartate and chitosan blends derivatized with -SH functionalities. Mar. Drugs 2010, 8                                                  
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Blends  were  reacted  with  mercaptoacetic  (thioglycolic)  acid  affording  the  –SH  derivative.  This 
polymer showed better arsenic-removal behavior (As removal > 22%) than other adsorbents, leading 
to a lower arsenic equilibrium concentration. 
Removal of arsenic from contaminated drinking water was also studied on a chitosan/chitin mixture 
that showed a capacity of 0.13 -equivalents As/g (pH = 7.0) [32]. 
Recently, removal of both As(III) and As(V) by chitosan-coated alumina or molybdate-impregnated 
chitosan was reported [33,34]. These methods show a very high adsorption capacity at pH = 4 (56.50 
and 96.46 mg/g for As(III) and As(V), respectively), but other interfering ions (i.e., phosphate) may 
limit or abolish the efficiency of this adsorbent. 
Chitin and chitosan were comparatively employed for remediation of chromated copper arsenate 
(CCA) preservative-treated wood in recent years due to release of chromium, copper, and arsenic 
elements from waste wood during land filling, burning, composting, and other disposal methods [35]. 
Limiting the analysis to As species only, chitin removed 63% of As from treated sawdust, while using 
the same amount of chitosan the recovery was only 30%. These results clearly show that even this 
acetylated  polysaccharide  can  be  efficiently  employed  for  arsenic  removal.  However,  chitosan  is 
generally preferred over chitin in the vast majority of applications [36,37]. 
3. Chitosan for As2O3 Incorporation and Delivery 
In a completely different field, arsenicals and compounds like arsenic trioxide (As2O3) have been 
used therapeutically in traditional Chinese medicine for a long time. Arsenic trioxide administered 
intravenously was reintroduced in the year 2000 by the US Food and Drug Administration as an 
anticancer agent for the treatment of acute promyelocytic leukemia (APL), even for patients with 
relapsed or refractory forms [38].  
It was hypothesized that the anticancer mechanisms of As2O3 may be due not only to the induction 
of  apoptosis  as  previously  reported  by  Zhang  [39],  but  also  by  reactivation  of  silenced  tumor 
suppressor genes through DNA demethylation [40]. 
Other studies reviewed by Cui et al. investigated the use of As2O3 in the treatment of solid tumors, 
including  liver,  prostate,  neuroblastoma,  head  and  neck,  gastric,  transitional  cell,  and  renal  cell 
carcinoma, esophageal, prostate, colorectal cancer, fibroblastoma, and melanoma [40]. 
However, the efficacy of As2O3 against human solid tumors is poor, even at a high As dosage. 
Consequently, different strategies aimed at increasing its efficacy such as local delivery (intratumoral 
injection) have been devised [41]. This strategy not only increases the localization of specific drugs in 
the tumor, but also reduces the unspecific uptake by other organs (targeted delivery) and presents an 
anti-invasive activity [42]. 
The incorporation of As2O3 with chitosan nanospheres to form novel arsenic-containing chitosan-
based nanocarriers represents an innovative strategy that might be exploited. Additionally, chitosan 
itself has been claimed to show antineoplastic activities tested both in vitro and in vivo [43] even if the 
results  are  still  controversial  [44].  These  nanovectors,  as  other  common  nanomaterials,  can  be 
potentially used for their ability to exploit the Enhanced Permeability and Retention (EPR) effect 
already used for the delivery of small molecules [45,46]. The EPR effect is based on the fact that 
tumor  cells  grow  quickly  and  stimulate  the  production  of  blood  vessels  for  nutrition  and  oxygen Mar. Drugs 2010, 8                                                  
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supply. These newly formed tumor vessels are usually abnormal in form and architecture. They present 
wide  fenestrations  where  engineered  systems  may  enter  and  deliver  their  cargo.  Therefore,  such 
delivery vehicles have the property to accumulate much more in tumor tissues than in normal tissues 
just exploiting their dimensions. To achieve the EPR effect, As2O3 can be therefore incorporated into 
chitosan nanospheres, which might assure a quite prolonged diffusion, biocompatibility and safety, 
while exploiting the EPR effect. An already reported example is represented by chitosan nanospheres 
[47].  These  nanospheres  have  been  studied  for  their  efficient  DNA  incorporation  and  
delivery properties.  
Alternatively, due to the versatility of chitosan to give larger biocompatible microspheres, As2O3 
can be incorporated into larger microspheres, as already achieved with DNA, using various fabrication 
methods [48]. Size and shape of these systems are important factors for several medical applications: 
to improve bioavailability (i.e., overcoming enzymatic or adsorption barriers and in the case of nasal 
administration the mucociliary clearance) and to prolong the residence time of drug delivery systems 
at the site of drug absorption [49].  
4. Interactions of Arsenite, Arsenate and Arsenic Trioxide (As2O3) with Chitosan 
It is generally believed that electrostatic interactions, metal chelation and ion pairs formations are 
the  three  main mechanisms  hypothesized  to  occur when a  metal is  adsorbed  by chitosan  [30,50]. 
Surface  adsorption,  chemi-  and  physisorption,  diffusion  and  adsorption-complexation  mechanisms 
may also occur [51] as a consequence of ion-exchange, hydrogen bonds, hydrophobic and van der 
Waals interactions. 
The  occurrence  of  interactions  between  chitosan  and  anionic  molecules  (dyes)  was  studied  by 
thermodynamic methods recognizing that chemisorption (ion-exchange, electrostatic attractions) is the 
most prevalent mechanism with the pH as the main factor affecting adsorption [52,53]. 
Figure 1. A model of interaction between chitosan and As(III) (arsenite), As(V) (arsenate) 
species and As2O3 oxide. 
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We hypothesized a model of interaction between chitosan and As(III) (arsenite)/As(V) (arsenate) 
species  or  arsenic  oxide  As2O3  that  we  have  presented  in  Figure  1.  The  arsenite  anion  may 
preferentially form electrostatic interactions with protonated chitosan amino groups. Arsenate may 
instead interact with the polymer through electrostatic interactions and hydrogen bonds. For what 
concerns the arsenic oxide As2O3, the interaction might occur mainly through hydrogen bonds. 
5. Conclusions 
From all the studies appearing in the literature over the last few years, it appears clear that the use 
of chitin and chitosan for toxic inorganic As removal or As2O3 delivery for tumor therapy is quite a 
neglected topic. We think that nanotechnology and biomedicine applied to these two aspects would 
help to solve not only some environmental pollution aspects, but also to improve the life quality of 
future generations and to devise novel prevention strategies and innovative therapeutic approaches. 
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